English
Home > Products > Venetoclax API

China Venetoclax API Factory

Our primary intention should be to offer our clientele a serious and responsible enterprise relationship, delivering personalized attention to all of them for Venetoclax API,CAS NO:1257044-40-8,ABT-199 API,Venetoclax,ABT-199, We're seeking forward to forming successful business enterprise romantic relationship with new shoppers in the around upcoming!
Venetoclax API, Our staffs are adhering to the "Integrity-based and Interactive Development" spirit, and the tenet of "First-class Quality with Excellent Service". According to the needs of every customer, we provide customized & personalized services to help customers achieve their goals successfully. Welcome clients from home and abroad to call and inquire!

Related Products

Hot Products

  • Azilsartan kamedoxomil

    Azilsartan kamedoxomil

    Product Name:Azilsartan kamedoxomil
    Molecular Formula:C30H25KN4O8
    Molecular Weight:608.65
    CAS Registry Number;863031-24-7
  • benzyl ((S)-2-((tert-butoxycarbonyl)aMino)-4-phenylbutanoyl)-L-leucyl-L-phenylalaninate

    benzyl ((S)-2-((tert-butoxycarbonyl)aMino)-4-phenylbutanoyl)-L-leucyl-L-phenylalaninate

    Product Name:benzyl ((S)-2-((tert-butoxycarbonyl)aMino)-4-phenylbutanoyl)-L-leucyl-L-phenylalaninate
    Molecular Formula:C37H47N3O6
    Molecular Weight:629.8
    CAS Registry Number:868540-15-2
  • Eptifibatide

    Eptifibatide

    Product Name:Eptifibatide
    Molecular Formula:C35H49N11O9S2
    Molecular Weight;831.96
    CAS Registry Number;188627-80-7
  • L-Phenylglycinol

    L-Phenylglycinol

    Product Name:L-Phenylglycinol
    Molecular Formula:C9H13NO
    Molecular Weight:151.21
    CAS Registry Number:3182-95-4
  • Hydrocortisone-17-Butyrate

    Hydrocortisone-17-Butyrate

    Product Name:Hydrocortisone-17-Butyrate
    Molecular Weight:432.55
    CAS Registry Number:13609-67-1
  • Voglibose

    Voglibose

    Product Name:Voglibose
    Molecular Formula:C10H21NO7
    Molecular Weight;267.28
    CAS Registry Number;83480-29-9
  • Related Blog
  • Reviews

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products...

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • What Is Misoprostol Used For?

    Misoprostol, a derivative of prostaglandin E1, can be used in the treatment of duodenal ulcer, the prevention of anti-inflammatory induced peptic ulcer and the prevention of early pregnancy.It has the function of inhibiting the secretion of gastric acid and preventing the formation of ulcer, thus protecting the gastric mucosa...

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept